# A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer

> **NCT05678010** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 54 (estimated)

## Conditions studied

- Solid Tumor
- Metastatic Solid Tumor
- Solid Carcinoma
- Solid Tumor, Adult
- Metastatic Tumor
- Metastatic Cancer

## Interventions

- **DRUG:** AZD1390
- **RADIATION:** Stereotactic Body Radiotherapy

## Key facts

- **NCT ID:** NCT05678010
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-17
- **Primary completion:** 2028-05-17
- **Final completion:** 2028-05-17
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05678010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05678010, "A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05678010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*